Asensus Surgical (ASXC)
(Real Time Quote from BATS)
$0.25 USD
0.00 (0.00%)
Updated Apr 30, 2024 11:00 AM ET
3-Hold of 5 3
F Value C Growth C Momentum F VGM
Income Statements
Fiscal Year end for Asensus Surgical, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 9 | 7 | 8 | 3 | 9 |
Cost Of Goods | 13 | 11 | 11 | 5 | 21 |
Gross Profit | -5 | -4 | -3 | -2 | -12 |
Selling & Adminstrative & Depr. & Amort Expenses | 75 | 72 | 62 | 58 | 142 |
Income After Depreciation & Amortization | -79 | -76 | -65 | -60 | -155 |
Non-Operating Income | 1 | 1 | 3 | 0 | 2 |
Interest Expense | 0 | 0 | 0 | 0 | 5 |
Pretax Income | -78 | -75 | -62 | -61 | -157 |
Income Taxes | 0 | 0 | 0 | -2 | -3 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -78 | -76 | -62 | -59 | -154 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -78 | -76 | -62 | -59 | -154 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -76 | -64 | -50 | -47 | -54 |
Depreciation & Amortization (Cash Flow) | 3 | 12 | 15 | 14 | 101 |
Income After Depreciation & Amortization | -79 | -76 | -65 | -60 | -155 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 249.69 | 236.49 | 226.96 | 70.81 | 17.74 |
Diluted EPS Before Non-Recurring Items | -0.30 | -0.29 | -0.24 | -0.63 | -4.22 |
Diluted Net EPS (GAAP) | -0.31 | -0.32 | -0.28 | -0.85 | -8.69 |
Fiscal Year end for Asensus Surgical, Inc falls in the month of December .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 5.43 | 1.09 | 1.08 | 0.98 |
Cost Of Goods | NA | 4.27 | 2.87 | 3.07 | 2.95 |
Gross Profit | NA | 1.17 | -1.78 | -1.99 | -1.97 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 17.28 | 18.48 | 18.87 | 20.38 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -16.11 | -20.26 | -20.86 | -22.35 |
Non-Operating Income | NA | -1.06 | 2.00 | 0.19 | 0.22 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -17.06 | -18.26 | -20.67 | -22.13 |
Income Taxes | NA | 0.18 | 0.06 | -0.01 | 0.09 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -17.24 | -18.32 | -20.66 | -22.22 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -17.23 | -18.32 | -20.66 | -22.22 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 264.35 | 256.18 | 239.57 | 238.28 |
Diluted EPS Before Non-Recurring Items | NA | -0.07 | -0.06 | -0.09 | -0.09 |
Diluted Net EPS (GAAP) | NA | -0.06 | -0.07 | -0.09 | -0.09 |